KKR, Warburg, Cinven eye bids for clinical trial firm PRA - sources
By Soyoung Kim and Greg Roumeliotis NEW YORK (Reuters) - Private equity firms KKR & Co LP, Warburg Pincus LLC and Cinven Ltd are wei...
Read More »By Soyoung Kim and Greg Roumeliotis NEW YORK (Reuters) - Private equity firms KKR & Co LP, Warburg Pincus LLC and Cinven Ltd are wei...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite the U.S. government offering hefty financial incentives to doctors for using...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Cholesterol-lowering drugs could be tied to more muscle problems than researchers pre...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - The proportion of middle-aged American men being treated for low testosterone more th...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Men taking drugs in the fluoroquinolone family were twice as likely to suffer serious k...
Read More »
By Sarah McBride SAN FRANCISCO (Reuters) - Microsoft co-founder Bill Gates is leading a $35 million investment in ResearchGate, a Be...
Read More »
By David Morgan WASHINGTON (Reuters) - U.S. Health and Human Services Secretary Kathleen Sebelius said on Tuesday that she talked to...
Read More »(This is a corrected version of a December 20, 2012 story that was erroneously issued on June 3, 2013 without the correction informa...
Read More »By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - Some call it neurological diversity, others see it as autism's ...
Read More »By Ben Hirschler LONDON (Reuters) - AstraZeneca is ending development of a rheumatoid arthritis pill that was one of its few late-st...
Read More »